David Campen
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Drug-Induced Adverse Reactions
- Pharmaceutical industry and healthcare
- Medical Terminology top 10%
Papers in
-
- Inflammatory mediators and NSAID effects 4
- Drug-Induced Adverse Reactions 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Co-authors
- David J. Graham (4 shared papers)Gerald Levy (2 shared papers)Stanford Shoor (2 shared papers)Michele M. Spence (2 shared papers)Rita L. Hui (2 shared papers)Craig Cheetham (1 shared paper)Wayne A. Ray (1 shared paper)Glenn R. Ehresmann (1 shared paper)
- Journals
- Journal of Vascular Surgery (3 papers)Journal of Clinical Oncology (1 paper)Health Affairs (1 paper)The Lancet (1 paper)The Permanente Journal (1 paper)
- Partner nations
- United States
In The Last Decade
David Campen
10 papers receiving 998 citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Pharmacology 496
- Medical Terminology 4
- Biochemistry 106
- Toxicology 42
- Pharmacology 107
Countries citing papers authored by David Campen
This map shows the geographic impact of David Campen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Campen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Campen more than expected).
Fields of papers citing papers by David Campen
This network shows the impact of papers produced by David Campen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Campen. The network helps show where David Campen may publish in the future.
Co-authors
The 24 scholars most cited alongside David Campen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study Hit paper breakdown → | 2005 | 683 |
| 2 | 1988 | 118 | |
| 3 | 1990 | 74 | |
| 4 | 1990 | 65 | |
| 5 | 2005 | 61 | |
| 6 | Candida septic arthritis in rheumatoid arthritis. | 1990 | 23 |
| 7 | 2000 | 18 | |
| 8 | 2002 | 12 | |
| 9 | 2008 | 8 | |
| 10 | 2005 | 2 | |
| 11 | 2013 | 0 |
About David Campen
David Campen is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Surgery, Rheumatology and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Vasculitis and related conditions (2 papers), Drug-Induced Adverse Reactions (2 papers), Peripheral Artery Disease Management (2 papers) and Vascular Procedures and Complications (2 papers). The work is most often cited by research in Pharmacology (496 citations), Medical Terminology (4 citations), Biochemistry (106 citations), Toxicology (42 citations) and Pharmacology (107 citations). David Campen has collaborated with scholars based in United States. Frequent co-authors include David J. Graham, Gerald Levy, Stanford Shoor, Michele M. Spence, Rita L. Hui, Craig Cheetham, Wayne A. Ray, Glenn R. Ehresmann, David A. Horwitz and Francisco P. Quismorio. Their work appears in journals such as Journal of Vascular Surgery, Journal of Clinical Oncology, Health Affairs, The Lancet and The Permanente Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.